webinar register page

Webinar banner
SBP Insights: Diabetes - Expanding the knowledge of types 1 and 2 diabetes reveals new drug targets. An exclusive conversation with Pamela Itkin-Ansari, Ph.D. and Randal J. Kaufman, Ph.D.
Do you, or does someone you know, have diabetes? Then you’re probably aware that it’s hard work to get—and keep—diabetes under control. In addition, you know how important it is to get a handle on it to avoid a host of dangerous health complications.

Improved ways to prevent and treat diabetes would benefit the more than 400 million people worldwide living with the disease. Join us to learn about recent discoveries in Type 1 and Type 2 diabetes research, direct from our leading researchers. They will discuss how their collaboration opened up an entirely new approach to effectively manage diabetes, and how biomarkers may lead to early detection and stave off this chronic condition. Hear about breakthroughs—including how our scientists are identifying novel drug targets to treat diabetes.

A Q&A session will follow the presentation to provide you an opportunity to personally connect with our scientists and have your questions answered.

About Sanford Burnham Prebys Medical Research Institute
Sanford Burnham Prebys is a preeminent, independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For more than 40 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children’s diseases, and is anchored by our NCI-designated Cancer Center and advanced drug discovery capabilities. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.

Nov 17, 2020 01:00 PM in Pacific Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.